Risk factors and management of pasireotide-associated hyperglycemia in acromegaly

Pasireotide, a multireceptor-targeted somatostatin analog with highest affinity for somatostatin receptor subtype (SST) 5, has demonstrated superior efficacy over the SST(2)-preferential somatostatin analogs octreotide and lanreotide. The safety profile is similar to those of octreotide and lanreoti...

Descripción completa

Detalles Bibliográficos
Autores principales: Gadelha, Mônica R, Gu, Feng, Bronstein, Marcello D, Brue, Thierry C, Fleseriu, Maria, Shimon, Ilan, van der Lely, Aart J, Ravichandran, Shoba, Kandra, Albert, Pedroncelli, Alberto M, Colao, Annamaria A L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774766/
https://www.ncbi.nlm.nih.gov/pubmed/33434154
http://dx.doi.org/10.1530/EC-20-0361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774766/
https://www.ncbi.nlm.nih.gov/pubmed/33434154
http://dx.doi.org/10.1530/EC-20-0361

Ejemplares similares